Anthrax News

Story in the Washington Post yesterday talks about a new anthrax drug, intended for treatment after exposure to the disease .

Human Genome Sciences and GlaxoSmithKline said Monday their experimental lupus treatment passed another key goal on its path to potentially becoming the first new drug for the disease in decades.

A panel of experts of the US Food and Drug Administration has recently asked for additional data to judge the efficacy of Human Genome Sciences Inc.

The BioMedReports.com FDA Calendar service includes a database with over 400 entries of pending new drug, biological agent, or medical device new product decisions at the FDA ; pending new submissions to the FDA; pending complete response letter re-submissions to the FDA; and pending clinical trial results.

A report prepared for a Food and Drug Administration panel scheduled to consider approval of Human Genome Sciences Inc.

Main Category: Bio-terrorism / Terrorism Also Included In: Immune System / Vaccines Article Date: 02 Oct 2009 Emergent BioSolutions Inc.

Scientists discover a gene in anthrax-causing bacteria may help defend against this form of bio-warfare. Spread of the deadly disease anthrax by spores of the bacterium Bacillus anthracis is a known terrorism risk and protection includes finding ways to treat the disease, according to an academic paper reviewed by Faculty of 1000 .

First Person INTERN TO THE LION by Zett-Alexandra Scheinbaum American Reporter Correspondent Washington, D.C. WASHINGTON, D.C., Aug.

Researchers at Albert Einstein College of Medicine of Yeshiva University have identified two small protein fragments that could be developed into an anthrax vaccine that may cause fewer side effects than the current vaccine.

OKLAHOMA CITY The National Institutes of Health has awarded two grants worth $26.3 million to the Oklahoma Medical Research Foundation for research into anthrax and to help train new scientists.

Alipurduar, Aug. 17: Jaldapara Wildlife Sanctuary is gearing up for a possible anthrax attack as a rhino calf is suspected to have died of the disease yesterday.

Emergent BioSolutions traded sharply higher after releasing earnings Friday morning .

Emergent BioSolutions traded sharply higher after releasing earnings Friday morning .

In an earlier post on IPBiz [ Standard Oil and I.G. Farben: patents and antitrust ], the interrelationship of I.G. Farben and Standard Oil of New Jersey [now ExxonMobil] was discussed.

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and August earnings reports.

Washington, July 25 : Early detection and quick treatment can save nearly 87pct of people affected from anthrax, finds a new study.

Human Genome gets new order for anthrax drug "Human Genome Sciences Inc said it received a second order for its drug ABthrax, which fights anthrax infection [sic], from the U.S. government.

Human Genome Sciences Inc. , a frequent newsmaker this week, more than doubled its quarterly revenue while shaving its quarterly losses down by 18 percent in the period from April through June, though it still fell short of analyst expectations.

Human Genome Sciences Inc. said Wednesday the U.S. government placed an additional order for its inhaled anthrax treatment ABthrax for $151 million.

Biotech drugmaker Human Genome Sciences reported positive results Monday for its experimental lupus drug, confounding analyst expectations and potentially clearing the way for the first new treatment against the inflammatory disease in a half century.